- Home
- News & Events
- In the News
In the News
91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Due diligence and beyond
Dr. Sandra Eagle outlines how due diligence has evolved from a discrete standalone technical assessment, to now being an integrated part of the holistic development continuum of an asset.
-
This news article, published on PM Live, highlights
-
The contribution of companies during the Covid-19 pandemic
Rose Kidd, President, Operations Delivery outlines the role 91黑料 played in the search for vaccines and treatments for Covid-19 in the American Chamber of Commerce Ireland 2023 US-Ireland Business Report.
2023 American Chamber of Commerce Ireland
-
This news article, published on Clinical Trials Arena, outlines as well as help to launch new medicines.
-
This news article, first published on Applied Clinical Trials, outlines that that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective.
-
91黑料 and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
-
This news article, first published on Contract Pharma, covers the .
-
This article describes some of the systemic factors that produce barriers at various stages of the rare disease drug development process, as well as identifies strategies to improve diversity in these trials
-
Brandon Early discusses how optimising trials designs at the earliest stages can help innovative biotech companies to maximise their available capital.
-
Helen Yeardley, Senior Vice President, Global Clinical Operations, discusses how 91黑料 is adapting to the global shortage of Clinical Research Associates in the industry.